IL17A and experimental autoimmune encephalomyelitis: IL-17A knockout (KO) or IL-17A blockade abolishes disease development in animal autoimmune models such as experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA) (2).